Skip to main content
Log in

ZK 90 695: A new antiarthritic drug with tissue targeting properties

  • Papers Given at the 12th European Workshop on Inflammation, Halle, Germany, May 30–31, 1990
  • New Substances
  • Published:
Agents and Actions Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. M. D. Francis, I. Fogelmann,99m Tc diphosphonate uptake mechanism on bone. InBone scanning in clinical practice. (Ed. I. Fogelmann), pp. 7–17, Springer-Verlag, London, 1987.

    Google Scholar 

  2. H. Fleisch,Biosphosphonates: A new class of drugs in diseases of bone and calcium metabolism. InHandbook of experimental pharmacology, Vol. 83, (Ed. P. F. Baker) pp. 441–465, Springer, Berlin/Heidelberg, 1988.

    Google Scholar 

  3. T. Storm, G. Thamsborg, T. Steiniche, H. K. Genant, O. H. Sorensen,Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. N Eng J Med322, 1265–1271 (1990).

    Google Scholar 

  4. C. N. Deuxhaisnes,The case of biphosphonates in pharmacology. InBiphosphonates, current states and future aspects; London 1990. Documentation of the International conference organized by IBC.

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hümpel, M., Günzel, P., Biere, H. et al. ZK 90 695: A new antiarthritic drug with tissue targeting properties. Agents and Actions 32, 22–23 (1991). https://doi.org/10.1007/BF01983302

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01983302

Keywords

Navigation